Publications

This section collects the most significant scientific contents of EGOI-PCOS members concerning the use of inositols alone or in association, both in basic research and for clinical application.

Also, the most relevant and updated literature on diagnosis and therapy of PCOS is gathered.

In particular, this collection includes the most recent original articles, clinical trials, reviews and meta-analyzes on the use of inositols especially in the gynecological, reproductive, metabolic, and endocrine fields.

Manuscripts inserted deal with important issues such as Polycystic Ovary Syndrome (PCOS), metabolic syndrome, insulin resistance, gestational diabetes with its complications, neurological defects for the unborn children linked to the nutritional deficiencies of mothers.

The extraordinary pharmacological utility of inositol

Sep 2015

Professor Bizzarri explains us the numerous activities of inositol in the body. This molecule is scavenger and protector of the intestine; reduces insulin resistance and the likelihood of developing diabetes; protects the processes involved into female and male fertility; it is useful in the treatment of certain cancers such as colon, lung and breast cancers.